Liver-targeted gene therapy: Approaches and challenges

Rajagopal N Aravalli1, John D Belcher2, Clifford J Steer2,3

  • 1Departments of Radiology, Cell Biology, and Development, University of Minnesota Medical School, Minneapolis, MN.

Insights

Novel gene therapy tools show promise for liver genetic disorders. Researchers are developing targeted gene approaches using advanced technologies to overcome limitations in treating liver diseases effectively.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Genetic Medicine

Background:

  • The liver is central to many inherited and acquired genetic disorders and metabolic diseases.
  • Current nucleic acid-based therapies for liver conditions face significant side effects and limitations.

Purpose of the Study:

  • To review current and emerging therapeutic strategies for liver-targeted gene therapy and gene repair.
  • To highlight advancements in genetic tools and delivery vectors for liver gene modification.

Main Methods:

  • Review of novel genetic tools including zinc-finger nucleases, transcription activator-like effector nucleases, and CRISPR-Cas9.
  • Examination of nonviral vectors like Sleeping Beauty transposons, PiggyBac transposons, and PhiC31 integrase.
  • Focus on efficient DNA and RNA delivery methods into liver cells.

Main Results:

  • Identification of advanced genetic tools for precise gene modification in the liver.
  • Evaluation of various nonviral vectors for effective gene delivery.
  • Emphasis on the critical role of efficient molecular delivery for therapeutic success.

Conclusions:

  • Targeted gene approaches using novel genetic tools and vectors offer promising therapeutic strategies for liver diseases.
  • Overcoming delivery limitations is key to advancing liver-targeted gene therapy and gene repair.
  • Continued research in this area holds potential for treating a range of liver genetic disorders.

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
28.2K
Gene Therapy00:59

Gene Therapy

4.9K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
94